Business & Industry
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
- Pfizer's Phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- Pfizer launches cost savings program on TrumpRx lowering drug costs for millions of Americans
- Sanofi announces the signing of a share buyback mandate for up to €1 billion
Research & Development
- Life-changing drug identified for children with rare epilepsy
- People with COPD commonly misuse medications
- Chemically ‘stapled’ peptides used to target difficult-to-treat cancers
- New study identifies growth hormone receptor as possible target to improve lung cancer treatment
- A highly precise target for medications against tropical diseases
- Aspirin not a quick fix for preventing bowel cancer
- Accelerating next generation medicine with new drug delivery platform
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis